Form 4: Hims & Hers CFO Exercises Options, Sells Shares
Insider Trading Report
Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and subsequently sold a portion of Class A Common Stock under a pre-arranged 10b5-1 trading plan.
Summary
- Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., executed transactions on January 20, 2026.
- Okupe exercised stock options to acquire a total of 9,067 shares of Class A Common Stock.
- The options exercised included 7,317 shares at an exercise price of $5.01 per share and 1,750 shares at an exercise price of $11.53 per share.
- Concurrently, Okupe sold 9,067 shares of Class A Common Stock at an average weighted price of $30.3423 per share, with prices ranging from $30.21 to $30.44.
- These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025.
- Following these transactions, Okupe directly beneficially owns 91,617 shares of Class A Common Stock and indirectly owns 7,853 shares through a trust.
- Okupe also holds 149,313 unexercised stock options with an exercise price of $5.01 and 42,996 unexercised stock options with an exercise price of $11.53.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can be seen as negative, the transaction was pre-planned under a 10b5-1 plan, which mitigates concerns about opportunistic selling. The exercise of options also indicates the stock price is above the strike price, which is generally positive.
Positives
- The exercise of stock options indicates that the options were 'in the money,' reflecting an increase in the company's stock price above the exercise price.
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which provides an affirmative defense against insider trading allegations, demonstrating adherence to corporate governance best practices.
Negatives
- The sale of 9,067 shares by a Chief Financial Officer could be perceived negatively by some investors, as it reduces the insider's direct equity stake.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The transactions were executed under a Rule 10b5-1 trading plan adopted on May 21, 2025, which allows insiders to pre-arrange sales of company stock to avoid accusations of trading on material non-public information. | 2025-05-21 | Enhances transparency and provides an affirmative defense against insider trading claims, aligning with good corporate governance practices. |
Stakeholder Impact
- Shareholders: The sale of shares by a key executive could lead to minor concerns about management's long-term commitment or perception of future stock performance, although the 10b5-1 plan mitigates this.
Key Dates
| Date | Description |
|---|---|
| 2021-09-01 | Date of Oluyemi Okupe Separate Property Trust establishment. |
| 2022-03-24 | Vesting start date for 7,317 stock options (1/48 monthly over 4 years). |
| 2023-04-01 | Vesting start date for 1,750 stock options (1/48 monthly over 4 years). |
| 2025-05-21 | Adoption date of the Rule 10b5-1 trading plan. |
| 2026-01-20 | Date of stock option exercises and subsequent sale of Class A Common Stock. |
| 2026-01-21 | Date the Form 4 was signed. |
| 2032-02-23 | Expiration date for 149,313 stock options with an exercise price of $5.01. |
| 2033-03-01 | Expiration date for 42,996 stock options with an exercise price of $11.53. |
Keywords
Hims & Hers Health, HIMS, Oluyemi Okupe, CFO, Insider Trading, Form 4, Stock Options, Share Sale, 10b5-1 Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.